That's pretty much it.
http://finance.yahoo.com/news/mesoblast-price-target-raised-14-122628577.html
"Maxim raised its price target for Mesoblast to reflect the company's acquisition of Prochymal and keeps a Buy rating on the stock."
mesoblast price target raised to $14 from $12
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.42 |
Change
0.025(1.79%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.42 | $1.41 | $423.8K | 300.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12480 | $1.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.43 | 117246 | 4 |
View Market Depth
| Last trade - 10.06am 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |